Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants-Reference-Cited by-同舟云学术

Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants

Published:2015-11-18 Issue:4 Volume:12 Page:946-954
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Gandhi Dulari J.,Dhaded Sangappa M.,Ravi Mandyam D.,Dubey Anand P.,Kundu Ritabrata,Lalwani Sanjay K.,Chhatwal Jugesh,Mathew Leni G.,Gupta Madhu,Sharma Shiv D.,Bavdekar Sandeep B.,Jayanth Midde V.,Ravinuthala Suresh,Sil Arijit,Dhingra Mandeep S.

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/21645515.2015.1100779

Reference13 articles.

1. Simplifying paediatric immunization with a fully liquid DTP–HepB–Hib combination vaccine: Evidence from a comparative time-motion study in India

2. Somatic Mutation of Human Immunoglobulin V Genes: Bias, Rate, and Regulation

3. A comparison of immunogenicity and safety of indigenously developed liquid (DTwPHB-Hib) pentavalent combination vaccine (Shan 5) with Easyfive (Liq) and Tritanrix + Hiberix (Lyo) in Indian infants administered according to the EPI schedule

4. Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children

5. A Multicenter, Prospective, Open-Label, Non-Comparative Study to Evaluate the Immunogenicity and Tolerance of a New, Fully Liquid Pentavalent Vaccine (DTwP-HepB-Hib Vaccine)

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants–A randomized study;PLOS ONE;2023-08-15

2. Combination Vaccines;Plotkin's Vaccines;2023

3. Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6–8, 10–12, and 14–16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled study;Vaccine: X;2022-12

4. A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months;Human Vaccines & Immunotherapeutics;2022-11-22

5. Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India;Vaccine: X;2022-04